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NECROTIZING FASCIITIS: A CUMMULATIVE REVIEW 
 
AND NEW TECHNIQUES IN EMERGENCY ROOM DIAGNOSIS  
 
NIMA KHOSHAB 
ABSTRACT 
 Necrotizing fasciitis (NF) is a rare and life threating soft-tissue infection specific 
to the skin’s fascia layer. It is most often encountered in the peripheries, abdominal wall, 
and perineum and has numerous etiologies and associated pathogens. Early diagnosis and 
rapid surgical debridement are essential in treating NF as the infection progresses rapidly 
and mortality rate increases significantly with time. The current difficulty in initial 
diagnosis is due to the lack of obvious skin findings early on in the infection. Laboratory 
tests, including the laboratory risk indicator for necrotizing fasciitis (LRINEC) score, gas 
on imaging tests, and physical exam findings are the current clues to an early diagnosis 
but official diagnosis can only be confirmed by surgical exploration and discovery of a 
lack of resistance to dissection in the fascia layer.  The LRINEC score analyzes one 
variable, specifically C-reactive protein (CRP), which is often not included in routine 
laboratory tests skin infections at the emergency department (ED). Furthermore, no 
specific set of physical exam findings has been distinctly associated with diagnosis of NF 
over other soft-tissue infections and the most specific imaging tests are too expensive for 
routine use. A new and modified LRINEC score based only on routine ED laboratory 
tests as well as an additional objective scoring system for physical exam findings are the 
next steps toward rapid diagnosis. This approach requires large-scale retrospective 
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statistical analyses of NF cases across the country for identification of the most prevalent 
physical exam findings and abnormal laboratory values. 
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INTRODUCTION 
 	   Necrotizing Fasciitis (NF) describes a variety of rare necrotizing soft-
tissue infections (NSTI) characterized by tissue necrosis specific to the fascia layer of 
skin.  It is imperative to distinguish NF diagnosis from other skin and soft tissue 
infections due to a high rate of mortality and the immediate demand for surgical 
debridement when NF diagnosis is indicated. As opposed to other soft-tissue infections 
NF is rapidly fatal unless quickly diagnosed and aggressively treated.46 
Specifically, NF primarily damages the subcutaneous fat layer (containing nerves 
and vascular structures) as well as the superficial and deep fascia layers. The anatomical 
differentiation between a variety of skin and soft tissue infections including erysipelas, 
impetigo, folliculitis, ecythyma, furunculosis, carbuncolosis, cellulitis, myonecrosis, and 
NF are included in Figure 1 below (Figure1).28  
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Figure 1: Anatomy of Soft-tissue Infections. Anatomical classification of skin and soft 
tissue infections by anatomical location within skin layers helps in the development of 
prognoses and treatment plan. Necrotizing fasciitis infections extend from the deep fascia 
to the superficial fascia and include all subcutaneous tissue including fat, nerves, arteries 
and veins. 28 	  
Hippocrates was the first to describe NF, in 500 BC as a complication of 
“erysipelas,” an acute and often recurring bacterial infection. Specifically he said “…the 
erysipelas would quickly spread widely in all directions. Flesh, sinews and bones fell 
away in large quantities…Fever was sometimes present and sometimes absent…There 
were many deaths. The course of the disease was the same to whatever part of the body it 
spread.” 19  
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In the early 1800s NF was described by a variety of different names including 
gangrenous ulcer, putrid ulcer, malignant ulcer, hospital gangrene, phagedena (“eating 
away”), phagedenic ulcer, and phagedena gangraenosa but by the mid-1800s two names 
predominated, phagedena and hospital gangrene.41 In England, between 1780 and 1850, 
two naval physicians, Sir Gilbert Blane and Thomas Trotter, along with a naval surgeon, 
Leonard Gillespie, delivered the first detailed description of NF in the English language.  
As described, amongst army and navy personnel, the disease was one of the most 
dreadful to appear, although “hospital gangrene,” as it was called, was rarely present 
amongst civilians at the time.41 Later in 1871, Confederate Army surgeon, Joseph Jones, 
the first to describe NF in the United States, again called it “hospital gangrene” and 
reported a total of 2,642 cases treated during the American Civil War.34  
By the early 1900s it appeared as if hospital gangrene was a disease of the past; 
Park, 1908, “Hospital gangrene so-called…is now practically never seen.”3 The current 
name, necrotizing fasciitis, first used by Wilson in 1952, describes the most consistent 
and significant aspect of the disease, necrosis of the fascia.71 Since the 1980s, a renewed 
interest in the pathology of NF has arisen. After a study by Stevens et al. reported 20 
patients with streptococcal shock, 11 of which were finally diagnosed with NF, the name 
“flesh-eating bacteria syndrome” became popularized in the media.62  
There has been some confusion in current literature regarding the exact definition 
of NF.64 There are a variety of terms, past and present, which refer to NF (including 
suppurative fasciitis, acute dermal gangrene, hemolytic streptococcal gangrene, 
progressive synergistic bacterial gangrene, necrotizing erysipelas, and Fournier’s 
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gangrene). The abundance of terms has added to the complexity of specifically defining 
NF and has exacerbated the challenge of accumulating accurate epidemiological statistics 
regarding diagnosis. (Fournier’s gangrene is a type of NF infection specific to the 
perineum and particular to males.)46  
In 1997, the incidence of NF was estimated to be 500-1000 cases per year and the 
global prevalence was 0.4 cases per every 100,000 people. There seems to also be an 
exponential increase in this rate recently, possibly due to a rise in the prevalence of 
concomitant risk factors.36 The ratio of men to women diagnosed with NF is 3:1, 
although the increased incidence in males is correlated with an increased incidence of 
Fournier’s gangrene, which is NF of the perineum specific to males. NF affects all ages 
but the highest rate of incidence has been reported in middle-aged and elderly patients 
(over 50 years of age). 40  
Most commonly, NF occurs in diabetics, alcoholics, IV drug users, 
immunosuppressed patients, and patients with peripheral vascular disease 16, 66 but also 
often presents in young, healthy individuals 13, 62 Approximately 50% of the patients 
diagnosed with NF have a history of skin injury leading up to the infection while 25% 
have experienced blunt trauma, and 70% have a minimum of one chronic illness.57   
The infection most often develops in the extremities, the perineum and genital 
area, or the abdominal wall.65 The extremities are the most common; 50% of total cases 
occur in a single lower limb and 33% occur in a single upper limb.57  
The average mortality of NF is controversial and the literature reports a variety of 
numbers in regard to morbidity. In one review of literature a median mortality ratio of 
	  	   5 
21.5 % was calculated 27 but median mortality ratios throughout the literature range all 
the way from 8.7% to 76%.28  When the infection presents in the extremities, the 
mortality rate is slightly lower than when the infection develops in the abdominal wall or 
perineum.56 Generally, without treatment the mortality rate of NF approaches 100%.46  
 
Etiology 
It is often unknown what inciting event leads to an NF infection and idiopathic 
causes have been recorded in anywhere from 13 to 31% of all patients. 45, 68 When the 
cause is identifiable it is most often due to trauma, either minor or major trauma.  In this 
case, trauma includes both external injuries and surgical wounds, such as perforated 
diverticulitis, necrotic cholecystitis, obstructive colon cancer with perforation, infection 
following the repair of an incarcerated hernia, appendicitis with perforation, small bowel 
perforation, or gastroduodenal perforation, as some of the most common.46 Furthermore, 
the pathogens causing NF can be introduced into subcutaneous spaces through any 
number of ways that involve a disruption of the overlying layers of skin. Other reported 
etiologies include cutaneous infections or ulcers,54 illicit IV drug injections,63 perirectal 
abscesses,63 animal or insect bites,63 incarcerated hernias,63 subcutaneous insulin 
injections,23 colocutaneous fistula,23 and renal calculi.68 There have also been reports of 
NF spreading hematatogenously from a distant site of infection throughout the body.44 
Table 1 is included for a more complete list of NF etiologies by location of subcutaneous 
infection site (Table 1).28 
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Table 1: Etiologies of Necrotizing Fasciitis. The table includes a comprehensive list of 
most common etiologies of NF infections organized by the specific site of infection. Most 
common sites of infection include extremities, abdominal wall, and perineum but other 
locations have been recorded as indicated in the table. Idiopathic etiology is also included 
for completeness as this is often the case in NF infections.28 
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Microbiology 
The majority of recorded NF cases are synergistic polymicrobial infections 
although there are cases of monomicrobial infections as well. One group reported that 
from 182 cases of NF studied, upon culture, 154 patients had polymicrobial infections 
while the remaining 28 patients developed NF from one single pathogen. The 154 cases 
of polymicrobial infections consisted of 4.4 organisms found on average upon wound 
culturing.20 A wide variety of pathogens can make up polymicrobial and monomicrobial 
NF infections. In the study above by Myers et. al, with 182 cases of NF, monomicrobial 
NF infections were most commonly caused by streptococcal species such as β-hemolytic 
streptococci (particularly group A streptococci or Streptococcus pyogenes).12, 20 
Interestingly, from all patients with NF described by McHenry et al., half the 
monomicrobial infections were caused solely by the S. pyogenes species, whereas only of 
2 of the 45 patients with polymicrobial infections had the S. pyogenes species isolated in 
their cultures.45 S. pyogenes is therefore often closely associated with monomicrobial 
infections.  
Polymicrobial infections in this case were most commonly caused by 
combinations of staphylococci species (particularly Staphylococcus epidermidis with β-
hemolytic streptococci), enterococci, Enterobacteriaceae species (commonly 
Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, and Pseudomonas 
aeruginosa), streptococci, Bacteroides/Prevotella species, anaerobic gram-positive cocci, 
and Clostridium species.12, 20 Another study found that 69% of NF infections were 
polymicrobial, 29% were monomicrobial, and no organisms grew in the remaining 2% of 
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cultures.45 The exact proportion of monomicrobial to polymicrobial NF infections 
slightly fluctuates throughout the literature but in general, polymicrobial cases including 
aerobic and anaerobic species are more common.30 This is an important consideration in 
the approach to antibiotic treatment of NF cases within the emergency department (ED). 
Due to the variability of bacterial species associated with NF infections in the literature, it 
is imperative that a broad range of antibiotics is given upon initial presentation until 
cultures and gram stain are determined. Guiliano et al. isolated up to 11 different bacterial 
species from an individual patient,26 further emphasizing the importance of initial broad 
range antibiotic treatment. The following table indicates a comprehensive list of 
pathogenic species that have been associated with NF infections to date (Table 2).28 
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Table 2: Pathogens of Necrotizing Fasciitis. The table above includes a comprehensive 
list of pathogens that have been recorded in NF infections including all bacterial species 
and even the rare fungal species. The wide variety of possible bacterial species includes 
gram-positive aerobes, gram-negative aerobes, anaerobes, and marine Vibrio species.28 	  
The prevalence of individual pathogens in a number of NF cases is reported in the 
following two tables (Table 3 and Table 4),1, 18 each from different patient populations, 
both indicating that most cases are polymicrobial and furthermore, that specific 
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pathogens consistently predominate. Beyond administering broad range antibiotics, it 
should be ensured that antibiotics targeting the most common NF species be administered 
in the ED upon initial presentation (See “Treatment” section). 
	  
Table 3: Prevalence of Pathogens in Necrotizing Fasciitis Cases. 73 patients with NF 
were studied and the species implicated in their infections were cultured. The prevalence 
of a variety of bacterial and fungal organisms recovered from these individuals is 
indicated in the table above. A total of 162 organisms were recovered from 73 patients 
and the majority of infections were polymicrobial. The Streptococcus species was most 
common amongst this group and included Streptococcus pyogenes, group B and G 
Streptococcus, and Streptococcus milleri.1 
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Table 4: Prevalence of Pathogens in Necrotizing Fasciitis Cases (2). Cultures 
representing 238 patients with NF. Microorganisms implicated in their infections were 
isolated. Streptococcus pyogenes was the most common species isolated, both 
independently and in combination with other species.18 
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NF is currently classified into four different types, each with different 
microbiological findings. 49 Type I is the most common of the four, also known as the 
polymicrobial type, in which a minimum of two pathogens are implicated and the 
infection is most often found in the perineum and trunk.46 Type II on the other hand, is 
known as the monomicrobial type, and is most often an infection of beta-hemolytic 
Streptococcus A (Streptococcus pyogenes), common in the extremities and often 
occurring in young, healthy individuals.70 Type II infections are also often associated 
with methicillin resistant, Staphylococcus aureus (S. aureus), which inflicts tissue 
necrosis through toxin release and leukocyte destruction. These specific Type II 
infections are usually localized to the limbs, and often occur in patients without 
significant co-morbidities, after small skin incisions. Type II infections have been highly 
correlated with the use of non-steroidal anti-inflammatory drugs (NSAIDs).59 In this 
manner, patient history upon ED presentation can provide significant insight for 
diagnosis; i.e. if a type II infection is suspected a specific treatment plan can be employed 
immediately. One study with 149 patients included 24 cases that led to mortality and 125 
patients that survived NF infections. Of the 24 persons that deceased, 14 individuals 
(58%) had monomicrobial infections. Of the 125 survivors, 50 (40%) had monomicrobial 
infections. Researchers concluded that monomicrobial infections, although less common 
than polymicrobial, presented with higher rates of mortality (P value of 0.09) than 
polymicrobial infections.19 
Monomicrobial NF infections that involve gram-negative rods, such as Vibrio 
spp., or Clostridium species comprise Type III NF infections. Vibrio vulnificus is an 
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aquatic bacterium found in Asia and is believed to be the most virulent Vibrio species 
indicated in NF. The species includes Vibrio parahemolyticus, Vibrio damsela, and 
Vibrio alginolyticus.27, 77 The Clostridium species on the other hand is a gram-positive 
bacteria that is often introduced following external injuries that cause devascularization, 
or surgical wounds, usually obstetric or intestinal. Clostridium infections are also more 
common among drug addicts.37  
Lastly, fungal NF infections, specifically Candida spp. and Zygomycetes make up 
Type IV infections, most commonly found in immune-compromised individuals.46 The 
following table categorizes the four types of NF infections by pathogen type, site of 
infection, and the co-morbidities that are most commonly associated with each type of 
infection (Table 5).46 
	  
Table 5: Four Types of Necrotizing Fasciitis. Classification of the four types of NF 
infections based on microbiological findings is indicated in the table. The commonly 
associated pathogenic species, site of infection, and co-morbidities are included.46 	  
If clinical signs of NF are indicated in the ED culture should be obtained as soon 
as possible. In contrast to cellulitis, where the leading edge of the lesion is aspirated to 
obtain culture material for gram stain from a wound, in NF, the necrotic center of the 
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lesion is the preferred site of collection.26 In 75% of all NF cases, diagnosis is obtained 
through microbiological cultures.25 In confirmed cases of NF, cultures obtained from 
sites of surgical debridement indicate a positive result in 80% of cases whereas blood 
cultures only indicate a positive result 25% of the time.6 Therefore, when NF is clinically 
indicated in the ED, it is imperative that culture be obtained as quickly as possible and 
that the necrotic center of the lesion be aspirated as opposed to collecting samples from 
blood or other locations within the wound.  
 
Pathophysiology 
NF infections begin in deeper layers of skin, which include the hypodermis and 
superficial fascia, initially causing very little outward change on superficial layers such as 
the dermis and epidermis.33 This fact makes early stage NF infections difficult to 
diagnose, as there are often little or no outward clinical changes. Usually, within 7 days 
of the provoking event, certain characteristic skin changes can be seen, although not all 
signs are clearly indicative of an NF infection.51 It is important for clinicians to 
understand this difficulty of diagnosis and maintain a high clinical suspicion.  
The most common histopathological changes found in NF include necrosis of the 
superficial fascia, thrombosis of blood vessels and suppuration. Other consistent changes 
include severe subcutaneous fat necrosis, severe inflammation of the dermis and 
subcutaneous fat, vasculitis, sometimes with endarteritis, and local hemorrhage. 7 Again, 
as reported by Umbert et al., the epidermis in most cases of NF initially shows no major 
changes.7 
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Fibrous attachments between subcutaneous tissue and fascia help limit the spread 
of infection but the lack of these attachments in the trunk and extremities allow for 
widespread infection in these regions.31 This leads to a slight variation in the time course 
of NF infections depending on initial location. Infections can progress for days to weeks 
but usually, the more significant life threating or limb-threating NF infections progress 
very rapidly within the first few hours post-infection.31 The spread of necrosis and 
infection is due to the synergistic actions of the variety of microbial agents involved as 
well as the enzymes and toxins produced by these pathogens.49 The earliest presentation 
of NF is usually in the form of a warm area of cellulitis displaying erythema, tenderness, 
and swelling with severe local pain.63 Erythema then spreads diffusely and the skin is 
reported to become shiny, smooth, and tensely swollen in the surrounding regions of the 
site of infection.71 Clinical signs of NF infections are evident in the following images 
(Figure 2 and Figure 3).30, 57 
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Figure 2: Presentation of Lower Extremity Necrotizing Fasciitis. In this case, the left 
lower extremity of a female diabetic patient with NF is demonstrated. She presents with 
painful swelling, erythema, and local heat as well as a bullae on her dorsum (indicated 
with black arrow). Her third phalanx indicates chronic gangrene (due to diabetes). Upon 
culture from the site of infection, Staphylococccus aureus (methicillin-sensitive) was 
isolated. Similar signs and symptoms are usually only present later in the timeline of the 
infection and should ideally be managed well before this point.57  
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Figure 3: Presentation of Lower Extremity Necrotizing Fasciitis (2). This 59-year-old 
female patient presents with erythema and edema in her right lower extremity from the 
medial malleolus to the tibia. Late stage infections often present with more rigorous signs 
including the bullae that are observed in two places along her leg.30 	  
The exact margins of the infection are often absent or difficult to discern and the 
infected area gradually changes to normal appearing skin. Within a few days, blisters and 
bullae, initially filled with serous fluid and later becoming hemorrhagic, develop on the 
infected skin and lead to a patchy, darker blue appearance.9, 69 When these changes are 
observed, it can be determined that the infection is well established within the 
subcutaneous region and necrosis of the superficial fascia and hypodermis is under way. 
This necrosis produces a foul-smelling, watery, and thin fluid called “dishwater pus” 71, 
evident in the following figure (Figure 4).27  
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Figure 4: "Dishwasher Pus". One of the commonly discovered positive macroscopic 
findings indicative of NF infections is called “dishwasher pus.” This is described as a 
bad-smelling, thin and watery fluid often found in the fascial layer at a wound site. The 
small black arrow indicates a cutaneous vein that has been thrombosed due to NF 
pathology.27 	  
Liquefactive necrosis, leading to “dishwasher pus”, is caused by bacterial 
enzymes such as lipases and hyaluronidases that degrade superficial fascia and fat 
(respectively).71 The process leads to the destruction of nerves and vascular structures of 
the subcutaneous layers causing the skin to become hypesthetic or even anesthetic.14 Four 
to five days after initial infection, usually following the presentation of “dishwasher pus”, 
the skin becomes seriously gangrenous.69 Patients begin to develop signs of sepsis 
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syndrome as bacterial organisms and toxins enter into their blood stream. Extensive 
tissue damage and systemic toxicity can take place, due both to bacterial toxins and 
endogenous cytokines.61, 78 The spread of bacteria, producing endo and exotoxins, 
throughout the subcutaneous tissue causes vascular thrombosis, tissue ischemia, and 
liquefactive necrosis terminating in multisystem organ dysfunction and eventually death, 
if not treated.60  
 
Comorbidities / Risk Factors 
There are several reported risk factors for NF including diabetes mellitus, over 50 
years of age, malnutrition, peripheral vascular disease, intravenous drug abuse, chronic 
alcoholism, atherosclerosis, obesity, and hypoalbuminemia.30 The following figure 
provides a comprehensive list of the most common risk factors leading to NF infections 
(Table 6).30 
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Table 6: Common Risk Factors for Necrotizing Fasciitis Infections. A comprehensive 
list of the most common risk factors leading to NF infections is indicated. These risk 
factors are indicative of an immune-compromised state in the patient, which may be one 
of the overarching lead factors in contracting an NF infection.30 	  
The most prevalent co-morbidity in NF patients is diabetes mellitus, present in 
approximately 40-60% of cases.27, 55 Some other common co-morbidities include liver 
cirrhosis, chronic heart failure, immunodeficiency, Addison’s disease, systemic lupus 
erythematosus, and pre-existing hypertension43, 77 The following table (Table 7) indicates 
the ethnic distribution of certain predisposing conditions to NF found in a New Zealand 
study. The data supports the fact that diabetes mellitus is the most common comorbidity 
among patients with NF, in this case, followed next by obesity.18 
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Table 7: Predisposing Conditions to NF (by ethnicity). Although significant 
differences between ethnicities were found with certain factors, such as diabetes mellitus, 
it was not established what this difference could be due to. The table demonstrates the 
most common pre-disposing conditions in cases of NF and presents similar findings to 
previous literature in which diabetes-mellitus is the most prevalent pre-disposing 
condition.18  	  
There are also certain factors that lead to a higher rate of mortality among patients 
diagnosed with NF. For example, a septic condition or hypotension at the time of hospital 
admission as well as chronic renal failure, elevated serum creatinine, and elevated blood 
urea all increase the risk of mortality.46 Risk factors and co-morbidities must be taken 
into serious consideration among hospital admission. A higher risk patient should be 
provided with more severe care. This understanding provides clinicians a separate avenue 
of analysis to apply when diagnosing a patient’s risk for NF. A patient with diabetes 
mellitus demands in depth consideration due to the severity and prevalence of their pre-
disposing condition.  
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Diagnosis 
Diagnosis of NF requires the evaluation of physical signs, laboratory tests, and 
imaging results along with a heightened sense of clinical suspicion. It is critical that NF 
be differentiated from other skin infections due to its rapid progression and high risk of 
mortality. In the ED, diagnosing NF is extremely time sensitive. The time between onset 
of symptoms and initial operation significantly increases mortality rate. It is crucial to 
minimize this time and promote rapid diagnosis in the ED. The following figure indicates 
the time between the onset of symptoms and initial operation and how this time effected 
the resulting survival rate in a cohort of patients with NF (Figure 5).74 
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Figure 5: Change in Cumulative Survival Rate by Time. As the time between initial 
onset of symptoms and first surgical debridement increases (in days), the cumulative 
survival rate in patients drops. Each individual point estimate along with four confidence 
intervals (95%) are calculated at 2, 4, 6, and 8 days after symptom onset in the above 
Kaplan-Meier curve.74 
  
The changes in overlying skin are initially difficult to detect. Therefore, a 
necessary tool for early diagnosis of NF is a high clinical index of suspicion. Beyond a 
high clinical index of suspicion there are several clues that allow differentiation of NF 
from other skin infections. Some of the most prevalent signs include local pain, fever, 
and indications of systemic toxicity while patient history and physical examination may 
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be relatively nonspecific. One systematic review of literature found that the most 
common diagnostic features include severe local pain, paucity of skin findings, fever, 
signs and symptoms of systemic toxicity, nonspecific results on physical exam, and 
uncommon soft-tissue gas.28 This lack of specificity demands further studies into clinical 
signs and symptoms with more clear indication of NF diagnosis.  
Other changes are often evident, although not all are specific to NF infections. In 
one study it was reported that sites of infection display erythema (80% of cases), 
induration (66%), tenderness (54%), fluctuance (35%), skin necrosis (23%), and bullae 
(11%).24 Another study compared NF infections to soft tissue infections to determine 
differentiating signs and symptoms and these yielded a number of indicators; increased 
tense edema (23% vs. 3%, p<0.0002), purplish skin discoloration (10% vs. 1%, p=0.02), 
and sensory or motor deficit (13% vs. 3%, p=0.03).67 In the case of an uncertain 
diagnosis, tense edema, purple skin discoloration, and sensory/motor deficit can be used 
as possible clues to an NF diagnosis although more specificity and more clues are 
required. Ecchymotic and erythematous skin lesions are common initial physical findings 
of NF. These symptoms may rapidly progress into hemorrhagic bullae, due to blood 
vessel occlusion in the fascia or muscle compartments. In this way, the presence of bullae 
is another important diagnostic feature of NF.57   
Fever and tachycardia (>100 beats/min) followed by hypotension (SAP <100mm 
Hg) and tachypnea (>20/min) are the most common vital sign abnormalities in patients 
with NF. The combination of these vital sign abnormalities and previously described skin 
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changes including pain and erythema, are currently the most useful signs for initial rapid 
suspicion of NF diagnosis over other soft tissue infections.57  
The official diagnosis for NF can only be made after surgical exploration and 
determination that the normally adherent fascia displays a lack of resistance to blunt 
dissection.27 Usually such surgical exploration is prompted after certain clinical signs are 
in place although some advocate immediate surgical exploration for biopsy and frozen 
section examination whenever there is a suspected diagnosis, even with lack of 
significant clinical findings.45  
Beyond physical examination, diagnosis may be suggested with the help of 
laboratory and imaging tests. Radiologic studies aid in diagnosing NF by detecting 
accumulated gas in soft tissue regions infected by anaerobic bacteria; this includes X-
rays, CT, ultrasound, and MRI.8, 22, 35, 76 These imaging techniques are more accurate for 
detecting soft-tissue gas than using physical examination.45 CT scanning in particular is 
more sensitive than plain radiographs and can even be helpful in identifying the spread of 
infection.29, 76 One group used MRI techniques to identify NF infections that require 
immediate surgical intervention and were able to accurately distinguish such infections 
from non-necrotizing cellulitis, avoiding the need for unnecessary surgical debridement.53 
Unfortunately this group was unable to go on and address whether the use of MRI 
imaging positively impacted mortality rates of the NF patients. Although these imaging 
techniques can prove to be useful in diagnosis, due to their cost effectiveness it is 
recommended that their use be reserved for very specific cases where diagnosis is highly 
uncertain and a definite diagnosis is needed to shape the immediate treatment plan.  
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Lastly, many laboratory tests are used to lead to a diagnosis of NF. Low et al. 
conducted a retrospective observational cohort study of 89 patients with confirmed 
diagnosis of NF using a control group of 225 patients admitted to the hospital for 
abscesses or severe cellulitis during the same time frame.73 Investigators studied the 
values recorded from laboratory tests in each patient’s chart to determine if certain 
variables provide significant insight into diagnosis of NF over other soft-tissue infections 
(i.e. cellulitis/abscess). Variables included age and gender as well as sodium, 
hemoglobin, creatinine, glucose, urea, potassium chloride and more. From these data 
certain variables were consistently and significantly varied in the cohort diagnosed with 
NF compared to control patients. These variables included C-reactive protein (CRP), total 
white blood cell (WBC) count, hemoglobin, sodium, creatinine, and glucose. The novel 
insight led investigators to develop a LRINEC (Laboratory Risk Indicator for Necrotizing 
Fasciitis) score based on laboratory results and the indicated suspicion of NF diagnosis. 73 
The following table (Table 8) indicates the cutoffs that were statistically indicated in the 
LRINEC study and the accumulation of points that are meant to provide various degrees 
of suspicion to clinicians on a diagnosis of NF.1 
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Table 8: LRINEC Score Breakdown. Six variables and their significant threshold as 
well as contributing scores formulate the laboratory risk indicator for necrotizing fasciitis 
(LRINEC) score used to help differentiate necrotizing from non-necrotizing soft-tissue 
infections. A maximum score of 13 is possible if each variable is measured beyond 
threshold. Variables include C-reactive protein, white-blood-cell count, hemoglobin, 
sodium, creatinine, and glucose. It is worth noting that C-reactive protein is the most 
impactful variable on the LRINEC score.1 	  
Based on these six measurements, each providing additional points to the overall 
LRINEC score, and statistical analyses, investigators found that an overall LRINEC score 
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greater than or equal to six (out of a maximum 13) should raise physician suspicion for 
NF. Furthermore, an overall LRINEC score greater than or equal to eight is strongly 
indicative of an NF diagnosis.73 
 
Treatment 
Treatment for severe NF requires multiple modalities, most importantly, rapid 
surgical debridement. Following surgical debridement, current approaches include 
antibiotics, supportive care, hyperbaric oxygen therapy, as well as vacuum assisted 
closure devices. 46 It is imperative that surgical debridement be performed as soon as 
possible, ideally within 12 hours of onset for full form NF, otherwise the increasing 
possibility of mortality and life-threating illness become more and more significant.46 
Surgical debridement should also be repeated within a 24-hour period depending on 
patient condition following the initial operation; this requires the monitoring of patient 
vital signs and the spread of infection.46 The risk of mortality increases by 7.5 times if 
only one surgical debridement procedure is performed. Furthermore, primary 
debridement after more than 24 hours of symptom onset increases relative risk of 
mortality by 9 times.48, 55 Rapid primary debridement, quickly followed by further 
necessary surgical explorations, is one of the most important actions in reducing the 
mortality of NF cases.  The following figure indicates how survival rate decreases as the 
time between hospital admission and first surgical debridement increases (Figure 6).74 
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Figure 6: Change in Cumulative Survival Rate by Time (2) The effect of increasing 
time between hospital admission and first surgical debridement on patient survival rate is 
demonstrated above. Cumulative survival rate was measured at 93.2% (95% CI; 99.8-
86.6) when surgery was undergone before the 24-hour point of hospital admission but 
drops to 75.2% (95% CI; 88.4-62.0) at 48 hours post-admission. Kaplan-Meier curve 
indicates the cumulative survival rate and an estimate of the 95% confidence interval at 
24, 48, 72, and 96 hours.74  
 
Most operations involve surgical debridement, fasciotomy, and necrosectomy and 
the average NF patient can require up to 40 additional operations depending on several 
variables including time and adequacy of initial debridement as well as symptoms of 
patient stability and co-morbidities.46, 55 Although surgical debridement removes tissue, 
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the current techniques decreases tissue loss in the long term by limiting the spread of 
infection throughout the fascia and therefore reducing the need for amputation.75 The 
following images show the extent and approach to tissue debridement currently used in 
NF treatment (Figure 7).46 (The figure also shows that incisions are made along Langer’s 
lines, allowing for less surgical scarring and improvement in wound healing. The extent 
of tissue excision is ideally extended until healthy tissue is visualized and limited to this 
edge. Healthy tissue that is salvageable should be kept but it is simultaneously important 
to ensure all infected tissue is removed, especially during the primary debridement). 46  
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Figure 7: Surgical Incision for Initial Debridement. This specific excision extends 
until healthy tissue is reached while non-infected skin is shown unattached. It is 
important to carefully remove as much necrotic tissue as possible and prevent the 
reappearance of infection within the fascial plane.46 	  
The next series of images depict pictures of NF infections of both the upper and 
lower extremities prior to any surgical intervention and after the first debridement 
operation. Large amounts of necrotic tissue and adjacent fascial planes have been 
removed indicating the degree of aggressive tissue removal that is necessary to prevent 
further infection (Figure 8 and Figure 9).27 
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Figure	   8:	   Upper	   Extremity	   Debridement.	   (a) NF of upper extremity before 
debridement demonstrating gangrene, erythema, edema, and ruptured bullae. (b) After the 
first surgical debridement, fascia layers extending up the upper extremity are removed 
and underlying tendons and muscle layers are exposed.27	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Figure 9: Lower Extremity Debridement. (a) Late stage NF of the left foot with severe 
skin discoloration and necrosis. (b) After complete surgical debridement the same foot is 
visualized demonstrating the depth reached upon removal and the extent of tissue 
removed from the site of infection. Tendons and muscle layers are exposed.27
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Beyond surgical debridement a combination of antibiotic therapy and supportive 
care should be provided. Supportive care is similar to that required for other critical 
patients and includes intensive fluid resuscitation, sufficient nutrition, and analgesics.68  
Antibiotic treatment on its own is not sufficient for treating NF infections due to 
ischemia of tissue, which does not allow for sufficient delivery of antibiotics to the site of 
infection. Tissue ischemia also limits polymorphonuclear-cell destruction by oxidation of 
bacteria and their toxins and therefore surgical debridement is required beyond antibiotic 
therapy on its own.32 With only antibiotic treatment and supportive care it has historically 
been demonstrated that mortality in NF infections is close to 100%.30 This is not to say 
that antibiotic therapy is not important, but that it should only be used in conjunction with 
rapid surgical debridement. Due to the variety of bacterial organisms often responsible 
for NF infections, a broad-spectrum range of antibiotics should initially be used until 
results for gram stain and culture are completed.57 The following table (Table 9) indicates 
a first-line approach in antimicrobial treatment against NF infections.57 
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Table 9: First-line Antimicrobial Treatments. The combination of antibiotic treatments 
demanded in mixed infections, Streptococcus infections, S. aureus infections, and 
Clostridium infections are indicated in the table above (organized by infection type).57 	  
Beyond surgical treatment, antibiotics, and supportive care, new supplemental 
treatments include hyperbaric oxygen and the use of a vacuum-assisted closure (VAC) 
device. Vacuum-assisted wound closure is now used by many surgeons and is thought to 
increase the efficiency and the time frame for wound closure.58 The vacuum-assisted 
wound closure device consists of a sponge attached to a vacuum pump, through tubing, 
that allows the passage of negative pressure, improving wound healing through 
microstrain.46 Specifically, the negative pressure that is regularly applied to the site of the 
wound throughout the healing process is meant to optimize oxygenation of tissue by 
increasing local blood flow.47 Accelerated formation of granulation tissue, fibroblast 
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growth, removal of wound fluids and a decrease in local edema at the site of the wound 
are other common benefits of VAC therapy.47 Before vacuum-assisted wound closure 
techniques, gauze therapy was a more common approach to wound closure but several 
studies have indicated that wound management and wound surface area are significantly 
improved with vacuum assisted therapy.50 Example of vacuum-assisted wound closure 
used to close a surgical wound (Figure 10)46: 
	  
Figure 10: Vacuum-assisted Wound Closure Therapy. Above is a sterile open-cell 
sponge at the site of a wound covered with adhesive tapes creating an air-tight 
environment. A vacuum pump is attached using tubing and continuous negative pressure 
is applied through the tube, ideally removing exudates, decreasing local edema and 
bringing wound edges closer together through microstrain.46 
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Hyperbaric oxygen is another supplemental treatment modality that still remains 
controversial in its specific efficacy toward treating NF wounds. Use of this modality 
requires placing the patient into a high oxygen environment under specific atmospheric 
pressures for variable durations of time.39 Hyperbaric oxygen theoretically increases the 
efficiency of leukocyte function, destroys anaerobic bacterial species, decreases edema, 
and stimulates the growth of fibroblasts and formation of collagen structures throughout 
the exposed tissue.15, 38 There have been several studies indicating that HBO treatment 
increases survival rates among patients requiring wound repair and treatment, but specific 
to necrotizing wounds none are completely conclusive. In treating necrotizing wounds 
specifically, no specific protocol for optimum treatment has yet been determined. 
 
PUBLISHED STUDIES 	  
 Diagnosis of NF in the ED requires several challenges for physicians. Certain 
distinguishing factors must be incorporated into their clinical suspicion in order to avoid 
misdiagnosis of a less severe soft-tissue infection and to maintain awareness of the rapid 
treatment that must be employed if NF is suspected. The study published by Low et al. 
introducing the LRINEC score provides a critical tool for the diagnosis of NF in an 
emergency room setting. Through the analysis of various results indicated in the 
following table the most significant variables contributing to the NF diagnosis were 
identified (Table 10).73 
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Table 10: LRINEC Score Analysis. Univariate and multivariate logistic regression 
analysis was applied to all variables tested including laboratory tests, age, and gender. 
From the thirteen variables, seven were excluded; they did not reach statistical 
significance at the level of p<0.05. The other six including CRP, hemoglobin, sodium, 
glucose, creatinine, and white blood cell count were determined as candidate diagnostic 
variables.73 
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The LRINEC score calculation requires the measurement of CRP, glucose, 
hemoglobin, creatinine, total WBC count, and sodium values. The most recent data 
collected by Neeki et al. at the Arrowhead Regional Medical Center ED in California 
retrospectively studying 139 adult cases of confirmed NF found the fraction of vital sign 
abnormalities, physical exam symptoms, imaging results, and abnormal lab values among 
the cohort to inform physicians and raise their sense of clinical suspicion on clues to 
diagnosis. The most prevalent signs and symptoms observed in this cohort study include 
local pain, erythema, edema, tachycardia, tachypnea, and fever.5 These signs and 
symptoms have been consistently observed as the most common across several other 
studies as well.28, 56, 66 Furthermore, Wong et. al also composed a study analyzing 
physical findings of NF patients upon hospital admission and found tenderness, 
erythema, warmth to palpation, tachycardia, and fever as the most common symptoms.74 
The following signs and symptoms as well as their prevalence among the individual 
patient population studied are indicated in the following table (Table 11).74 
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Table 11: Prevalent Physical Exam Findings. A total of 89 patients with necrotizing 
fasciitis and the prevalence of their signs and symptoms upon hospital admission are 
presented above. In this case, swelling (edema) is not included in the table but was 
observed in 82 of the 89 patients (92.1%).  Erythema, tenderness, and warm skin to 
palpation were the most common physical findings in this cohort.74 	  
Early diagnosis is critical in patients with NF and the time until first surgical 
debridement is a significant indicator of patient mortality. Primary debridement delayed 
more than 24 hours after symptom onset increases relative risk of mortality by 9 times.55 
Diagnosis in an emergency setting is the focus here and although the LRINEC score and 
the signs and symptoms can provide dramatic insight to a physician, it is essential to also 
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maintain a high clinical suspicion for NF.  Once diagnosis has been confirmed and a 
broad spectrum of antibiotics has been administered, the next immediate step is surgical 
debridement in the operating room.  
Techniques in surgical debridement have been normalized in most cases of NF 
and involve incision at the site of maximum fluctuance followed by cuts extending 
parallel to the skin’s Langer lines to minimize future scaring and maximize rapid wound 
healing. This approach is also thought to decrease the need for future amputation by 
limiting the course of infection throughout the fascial plane and therefore minimizing the 
loss of tissue.42 The most important aspect of surgical debridement is that it be done early 
and that it also be followed up within the next 24 hours and in the future with further 
debridement and tissue exploration as needed.55 The extent of tissue that should be 
initially removed remains controversial due to reports of microscopic pathologies 
discovered in normal appearing skin around the site of infection.3 For this reason, many 
groups have encouraged adequate and aggressive excision of tissue, especially upon the 
first operation.10 In one case, up to 45% of a patients surface area was excised with 
recorded recovery and survival.10  
The majority of treatment for NF is otherwise standardized as described by Roje 
et al. and begins with general resuscitation if the patient is in shock, followed by a broad 
range of antibiotics covering anaerobic and aerobic pathogens. Next, the patient should 
receive surgical debridement in the operating room; at this time cryosections, gram stain, 
and culture should be obtained from the wound for biopsy and specified diagnosis. 
Repeated surgical debridement should be continued regularly and an adjusted regiment of 
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antibiotics (based on cultures) should be administered until the patient’s infection is 
under control. Follow-up debridement and skin grafts should be continued as needed. 55 
In one study, the median number of follow up surgical debridement operations was four 
but if debridement as well as skin grafting procedures are considered, the average rises to 
33 follow up procedures.21, 55 Lastly, it is recommended that antibiotic therapy be 
continued up for 3-5 days following the termination of all signs and symptoms of soft 
tissue infection.55  
 In regards to VAC therapy, the current evidence is not completely conclusive on 
its benefits. The lack of negative effects recorded across all studies as well as the minor 
improvements in patient comfort as a result of the therapy have increased the use of VAC 
therapy in NF treatment and for general wound care.47   The alternative to VAC therapy 
consists of covering the surgical wound site with saline wet-to-dry dressings that are 
regularly changed for cleanliness and optimal healing. A previous study that compared 
this conventional therapy to the use of VAC therapy found that there was no significant 
difference in wound healing as a result of either treatment. On the other hand, VAC 
therapy significantly lessened patient pain throughout the process, increased patient 
mobility, and decreased the number of dressing changes that were required.52 Another 
case study found that VAC therapy among NF patients significantly reduced hospital 
admission time and general patient discomfort and proved effective in not only cleaning 
open wounds but also disrupting the process of fasciitis specific to NF infections.17 Other 
groups have studied the effectiveness of VAC therapy in treating acute and chronic 
wounds distinct from NF infections. Generally, VAC therapy, with respect to wound 
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care, has demonstrated a faster rate of wound healing when compared to conventional 
treatments and a reduction in the hospital stay period and costs of patient care.4 VAC 
therapy is promising in its ability to decrease patient discomfort and improve patient 
satisfaction throughout the recovery process.4 
 
RESULTS 
 
The LRINEC score is an important tool for clinicians and has demonstrated 
significant success in the prediction of NF diagnosis. Wong et al. were able to separate 
patients in their retrospective observational cohort study into three different risk level 
categories depending on calculated LRINEC score. LRINEC score less than or equal to 5 
indicates low risk and corresponds to a probability of less than 50% for developing an NF 
infection. LRINEC score of 6-7 indicates moderate risk and corresponds to a probability 
of 50-75% for developing NF. Lastly, a LRINEC score greater than or equal to 8 is 
indicative of the high-risk category and corresponds to a greater than 75% probability of 
developing NF.73 The maximum LRINEC score obtainable is 13 and an official cutoff for 
probable diagnosis is made at 6. Using this model they calculated a positive predictive 
value of 92% (with a 95% confidence interval, 84.3-96.0) and a negative predictive value 
of 96% (95% confidence interval, 92.6-97.9) for the LRINEC score cutoff.73  
A validation cohort was also used to externally confirm the LRINEC score model. 
In this case, 56 patients with confirmed NF diagnosis and 84 control patients again with 
cellulitis, from a different hospital, were evaluated. The model was confirmed through 
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external validation and demonstrated an area of 0.976 (95% confidence interval, 0.955-
0.997) under the receiver operating characteristic curve. (If a predictive model functions 
with perfect accuracy the area is 1.0).73 The receiver operating characteristic curve 
demonstrating the accuracy of LRINEC score diagnosis is indicated in the following 
figure (Figure 11).73 
	  
Figure 11: LRINEC Score Accuracy of Diagnosis. To validate the LRINEC model an 
external cohort from a separate hospital of 56 patients diagnosed with NF and 84 control 
patients with abscesses or severe cellulitis were compared. In this “validation” cohort, 
CRP values were only available for 87.9% of the 140 patients but the model was 
otherwise found to be reliable with an area under the receiver operating characteristic 
curve (ROC) of 0.976 with 95% CI between 0.955 to 0.997.73  
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In the developmental cohort and external validation cohort, 89.9% and 92.9% 
respectively, of patients with NF had a LRINEC score greater than or equal to 6. 
Likewise, only 3.1% and 8.4% respectively, of control patients in the two groups had a 
LRINEC score greater than or equal to 6.73 The following figure (Figure 12) 73 combines 
both the developmental cohort and the validation cohort to stratify patients into low, 
moderate, and high-risk categories based on LRINEC score.  
	  
Figure 12: Categorical Severity by LRINEC Score. Patients were stratified into three 
groups (low, moderate, and high risk for NF diagnosis) based on LRINEC score values. 
Each level risk group correlates to a certain probability of developing an NF infection. 
Low risk group (LRINEC ≤ 5); moderate risk group (LRINEC 6-7); high risk group 
(LRINEC ≥ 8).73 
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Beyond the LRINEC score, clinicians should maintain an elevated level of 
suspicion for NF and also look to physical exam signs and symptoms. When Neeki et al. 
retrospectively studied 139 patients with a confirmed diagnosis of NF over a seven-year 
period at Arrowhead Regional Medical Center (ARMC), the following signs and 
symptoms prevailed: local pain (85.9%) was the most common physical exam symptom 
in NF patients followed by erythema (67.4%), edema (58.5%), and tenderness to 
palpation (35.0%). In regards to vital signs, the most common abnormality was 
tachycardia (heart rate > 98 beats per minute) (75.6%), followed by tachypnea 
(respiratory rate > 19 breaths per minute) (53.3%), and fever (temperature > 100.4 
degrees Fahrenheit) (47.4%). Imaging exams indicated gas on CT in 62.5% of cases and 
gas on X-ray in 22.2% of cases. Lab values indicated values of D-dimer > 250 in 97.0% 
of patients, glucose > 110 in 74.1% of patients, bandemia > 9 in 71.9% of patients and 
lactate > 2.1 in 56.4% of patients.5 
 
DISCUSSION 
 
Current literature proposes several signs and symptoms indicative of NF 
infections for clinicians to consider when diagnosis is suspected. Furthermore, the 
LRINEC score has demonstrated considerable accuracy in diagnosing NF infections over 
other soft-tissue infections. Still, the scarcity of skin findings, the rare instance of these 
infections, and a lack of proper clinical suspicion causes cases of NF to often go missed 
or misdiagnosed. In the developmental cohort of 89 patients with NF from the 
retrospective study that was used to develop the LRINEC score model, only 14.6% (13) 
	  47 
were initially admitted for necrotizing fasciitis. In the remaining 76 (85.4%) patients, 
there was no suspicion or diagnosis of NF until after hospital admission, essentially 
delaying surgical debridement and increasing the possibility of mortality.73 If the 
LRINEC score was applied in these cases, there could have been a significant 
improvement in time to initial surgical debridement and therefore in mortality rate. From 
the 89 patients, 80 of them (89.9%) had a LRINEC score retrospectively calculated to be 
greater than or equal to 6 (the minimum cutoff for increased clinical suspicion).  
 The LRINEC score has minor complications of its own that may require revision. 
Unfortunately, the most impactful variable required to calculate the score is a CRP value. 
This lab result, if greater than the indicated threshold, adds 4 points to the LRINEC score. 
All other variables, if significant, can add a maximum of 2 points to the LRINEC score. 
In this case, the CRP value is heavily weighted in a LRINEC score calculation. 
Unfortunately, the CRP value is not always measured in an emergency room setting and 
was often not collected in the study that initially developed the LRINEC mode. This 
laboratory test requires a specific order from clinicians and is not included on the basic 
laboratory tests that are routine for skin infections, including the Complete Metabolic 
Panel (CMP) or Basic Metabolic Panel (BMP), and Complete Blood Count (CBC) blood 
tests. For this reason, it is critical to develop a new model of the LRINEC score, namely a 
modified LRINEC score. Future studies need to be initiated to retrospectively study a 
larger number of NF cases throughout the nation to statistically develop a modified 
LRINEC score based solely on laboratory results indicated in basic ED lab tests. This 
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advancement would ensure that less NF diagnoses are missed in the ED and rapid 
evaluation will decrease the time to first surgical debridement.  
 Furthermore, it is important to analyze the signs of NF beyond only laboratory 
tests. A retrospective observational study with a very large number of NF cases is 
required in order to determine immediate clues to NF diagnosis through physical 
examination. Although the pathogens may vary greatly, it is evident both through the 
most recent analyses by Neeki et al and past literature that certain physical exam signs 
are consistent among patients with NF. The consistencies and distinctiveness in clinical 
signs have not yet been statistically analyzed to the point of developing a scoring system 
similar to the LRINEC score. The analysis and determination of the most prominent 
clinical signs such as tachycardia, fever, local pain, and others can lead to an objective 
scoring system further assisting clinicians in their diagnosis of NF. Using the most 
prominent signs of NF, a diagnostic measure must be made that is meant to increase 
clinical suspicion depending on the number of signs that are, or are not present.  
 A modified LRINEC score along with a scoring system set up for distinguishing 
clinical signs of NF will greatly decrease the chances of missing a diagnosis. By properly 
educating clinicians on the implications of this serious infection and the signs and 
symptoms that come along with it, it is possible to lessen the rate of mortality in NF cases 
across the country. Statistical analyses of routine laboratory results and clinical signs 
from past and present cases of NF are an imperative next step. Through this in depth, 
large-scale analysis, a confident method of NF diagnosis for emergency departments 
across the country will arise.  
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 Once a confident method of diagnosis has been established, routine treatment, 
which is based primary on surgical debridement, should proceed as current methods 
suggest. There is no current method allowing specification of the required antibiotics 
based on initial lab tests and clinical signs and therefore a broad spectrum is necessarily 
administered until cultures have been resulted. Hyperbaric oxygen therapy remains 
controversial and it is uncertain whether it is beneficial in most cases. Previous studies 
have not applied proper controls and remain open to criticism. To determine the potential 
benefits of hyperbaric oxygen therapy, similar NF infections in matched patients must be 
compared. The challenge lies in the variability of NF infections. Depending on 
comorbidities, demographics, location of infection, and several other factors, it is difficult 
to match individual patients into treatment and control groups for hyperbaric oxygen 
therapy. The possible benefits that may arise from successful HBO therapy warrant the 
need for future studies. Before the use of HBO therapy is widely suggested in all cases of 
NF wound healing, it is important that large-scale studies with proper controls be set in 
place to determine the effectiveness of the treatment. 
 On the other hand, vacuum-assisted closure therapy has recently demonstrated 
more promising results for wound healing after surgical debridement. One of the most 
recent case reports employing VAC for wound healing, by Mizuguchi et al. demonstrated 
successful treatment of a potentially lethal case of NF, of a 58 year-old male, reaching 
from the lower leg to the perineum. Following surgical debridement, VAC therapy was 
applied before skin grafting procedures and notably expedited wound healing as 
compared to conventional therapy. The therapy also greatly improved comfort levels 
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during the process of healing, for both the patient involved and the medical staff 
managing his wounds.47  The case can be used as a model for treatment of severe NF. The 
successful transformation and wound healing process are demonstrated in the images 
below (Figure 13).47 
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a)      b) 
 
c)      d) 
 
Figure 13: Successful Treatment of Necrotizing Fasciitis Infection. (a) Status-post 
second surgical debridement (b) VAC therapy applied to site of wound after debridement 
(c) Status-post sixth surgical debridement and VAC therapy; healthy granulation tissue 
present throughout (post-operative day 21) (d) Site of infection healed using mesh-graft 
skin procedure to cover wound.47 
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 Beyond this individual case, VAC therapy has provided promising results in cases 
of NF wound management as well as the management of a variety of other acute and 
chronic wounds.47 Although its application in managing cases of NF infections may only 
alleviate and improve minor factors in wound care and patient satisfaction, the lack of 
noted negative effects warrants its application in future cases. The improvements in cost, 
decreased hospital stay, and patient comfort indicate that the treatment should be widely 
applied in addition to other current conventional NF treatment. VAC therapy has not been 
indicated to decrease patient mortality but its application will be a successful step toward 
better patient management.  
 The greatest improvement in patient mortality can be made through early 
diagnosis in emergency departments leading to rapid surgical treatment and minimization 
of worsening symptoms and the spread of infection. Future studies are necessary to 
develop a modified LRINEC score from basic ED laboratory tests as well as an objective 
scoring system for the clinical signs and symptoms that most commonly accompany NF 
infections. Through the development of these two models and an advancement of clinical 
suspicion through physician education, the diagnosis of NF can become standardized and 
conventional.  
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